A multi-center, randomized, double-blind, placebo-controlled efficacy and safety study of testosterone gel 1.62% for the treatment of hypogonadal men.

Trial Profile

A multi-center, randomized, double-blind, placebo-controlled efficacy and safety study of testosterone gel 1.62% for the treatment of hypogonadal men.

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 01 Jul 2011 Results published in the Journal of Sexual Medicine.
    • 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society
    • 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top